Modified adiponectin polypeptides and their uses
A technology of adiponectin and modifiers, applied in the field of adiponectin polypeptides, can solve problems such as lack of reproducibility, loss of protein activity, and slow reaction of derivatives
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example
[0634] The following examples are offered to illustrate, not limit, the claimed invention.
example 1
[0636] This example describes one of several potential sets of criteria for selecting preferred sites for incorporation of non-naturally encoded amino acids into adiponectin.
[0637] This example illustrates how to select preferred sites within the adiponectin polypeptide for introducing non-naturally encoded amino acids. The crystal structures of adiponectin, adiponectin dimers, adiponectin trimers, and adiponectin multimers were used to determine preferred locations at which one or more non-naturally encoded amino acids may be introduced. Other adiponectin structures (eg, from computer modeling, etc.) can be employed to examine potential variations in major and minor structural elements between crystal structure datasets. The coordinates of these structures can be purchased from the Protein Data Bank (PDB) (Berstein (Berstein) et al. J. Molecular Biology 1997, 112, p. 535) or through the information available on the World Wide Web at rcsb.org. Acquired from The Research Co...
example 2
[0643] This example details the cloning and expression of hGH polypeptides including non-naturally encoded amino acids in E. coli. This example also describes a method for assessing the biological activity of modified hGH polypeptides, and these cloning, expression and assessment techniques can also be used for adiponectin polypeptides of the invention.
[0644] Methods for cloning hGH and fragments thereof are described in detail in US Patent Nos. 4,601,980; 4,604,359; 4,634,677; 4,658,021; 4,898,830; The sequences of hGH or the mature form of hGH lacking the N-terminal signal sequence are included in Patent Nos. 4,601,980; 4,604,359; 4,634,677; 4,658,021; 4,898,830; , each incorporated herein by reference for all purposes.
[0645] hGH containing non-naturally encoded amino acids was expressed using an introduced translation system comprising an orthogonal tRNA (O-tRNA) and an orthogonal aminoacyl tRNA synthetase (O-RS). O-RS preferentially aminoacylates O-tRNAs with non-n...
PUM
| Property | Measurement | Unit |
|---|---|---|
| molecular weight | aaaaa | aaaaa |
| molecular weight | aaaaa | aaaaa |
| molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 